Stock Information
AbbVie Inc (ABBV)
Ticker Symbol: ABBV
Exchange: NYSE
Sector: Biotechnology
Market Cap: $453,111.69 mil
Piotroski score: 7
PE Ratio: 74.27
EPS (TTM): 3.56
Revenue (TTM): $36.36 M
Dividend Yield: 4.47%
ROE: 95.59%
Latest News
-
Oruka Therapeutics' Psoriasis Treatment Maintains 'Competitive Profile' After Positive Clinical Data, UBS Says
Thu, Sep 24, 2026 5:02 PM
-
Pfizer or AbbVie: Which Big Pharma Stock Is the Better Pick?
Thu, Sep 24, 2026 2:45 PM
-
Beyond Imbruvica: Can AbbVie Rebuild Its Oncology Portfolio?
Thu, Sep 24, 2026 2:03 PM
-
EPKINLY® receives Health Canada Approval for Adults with Follicular Lymphoma
Thu, Sep 24, 2026 11:01 AM
-
Prediction: Here's What $10,000 Invested in AbbVie Stock With Dividends Reinvested Could Be Worth in a Decade
Thu, Sep 24, 2026 4:50 AM
-
Nvidia Backed This AI Drug Startup. AbbVie Just Became a Partner Before Its IPO
Wed, Sep 23, 2026 6:42 PM
-
AbbVie: Revenue Pressure And Weakening Earnings Support A 'Sell'
Wed, Sep 23, 2026 5:40 PM
-
What Is AbbVie No Longer Telling You?
Wed, Sep 23, 2026 5:18 PM
-
What Is The Best Case For Pfizer Stock?
Wed, Sep 23, 2026 4:37 PM
-
Recent Filing Shows That Rep. Pete Sessions Sold Over $100K Worth of Apple Stock
Wed, Sep 23, 2026 11:00 AM
Key Financials
Financial data not available
